Recombinant avian influenza vaccine and uses thereof
US8394384B2 · kind B2 · utility
1Cited by
7References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 30, 2009 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Mar 13, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.